Copies of letters sent to healthcare professionals in March 2013, to inform of new safety information and advice:
| Date sent | Medicine | Safety information |
|---|---|---|
| 18 March 2013 | Belatacept (Nulojix▼) |
Increased rate of graft rejection with belatacept when concurrent corticosteroid therapy is tapered too rapidly. |
| 20 March 2013 | Cinacalcet (Mimpara) |
Fatal case of hypocalcaemia in a paediatric patient – reminder that cinacalcet is not approved for use in children. |